068940 — Cellfie Global Co Balance Sheet
0.000.00%
TechnologySpeculativeMicro Cap
- KR₩29bn
- KR₩28bn
- KR₩34bn
Annual balance sheet for Cellfie Global Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS/A | ARS/A | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 13,918 | 19,216 | 4,793 | 4,808 | 5,737 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,621 | 2,536 | 6,608 | 5,572 | 2,949 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 26,448 | 31,355 | 25,607 | 21,205 | 16,835 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,671 | 7,052 | 8,835 | 8,070 | 5,906 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 35,258 | 39,925 | 37,999 | 32,935 | 27,980 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13,228 | 22,131 | 16,338 | 12,637 | 8,884 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 18,353 | 32,037 | 18,701 | 14,306 | 10,201 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 16,906 | 7,888 | 19,298 | 18,630 | 17,779 |
Total Liabilities & Shareholders' Equity | 35,258 | 39,925 | 37,999 | 32,935 | 27,980 |
Total Common Shares Outstanding |